This past month, Congress passed a flurry of bills dedicated to stopping the devastation of the opioid crisis. One focus is on stopping illegal opioid imports from coming in though the U.S. mail. The Synthetics Trafficking and Overdose Prevention Act, which passed in the House, is one such bill. But as I wrote in the The Hill last year, the STOP Act could also enable the FDA to more easily prevent Americans from importing lower-cost, safe and effective medicines from Canada and other countries.
The FDA is also fighting the opioid crisis by scrutinizing the Internet as a channel of illegal sales. That, too, could lead to the curtailment of access to lower-cost, imported medicines from pharmacies, ones which don’t sell opioids or controlled drugs at all, but do help people afford medicines.
Ideally, people who use a search engine, such as Google, find information based on an objective search algorithm. With tens of millions of Americans not filling prescriptions due to high prices here at home, many are Googling to find and order cheaper medication from international online pharmacies. (more…)
Tagged with: Eli Lilly, Google, Kaiser Family Foundation, Sheryl Sandberg, Volokh
Central to Big Pharma’s lobbying efforts is relying on drug company-funded “nonprofit” groups to sanitize their goals under the veneer of charity. Investigative reporting in Tarbell, a media organization founded by healthcare activist Wendell Potter, shows that drug companies, namely Eli Lilly, successfully lobbied the Obama administration to make Internet companies embrace policies that curtail online access to affordable medication.
These pharma-funded nonprofits engage fellow industry-tied patient groups, the media and people, promoting the idea that rogue online pharmacies and safe international online pharmacies are the same thing. Their message: don’t buy lower-cost medications online from other countries because it’s too dangerous.
That message is an outright lie.
Tagged with: Alliance for Safe Online Pharmacies, ASOP, Big Pharma, Eli Lilly, LegitScript, Obama Administration, tarbell
There are not many issues you can hear both Republicans and Democrats clapping about in unison, but high drug prices is definitely one of them. Echoing his 2016 campaign, President Trump again proclaimed during his State of the Union address Tuesday night that his administration is determined “to make fixing the injustice of high drug prices one of our top priorities.”
Speeding up the approval of lower-cost generics was noted by Trump as “exciting progress,” but nothing substantial has been done by the Trump administration on drug prices. The appointment of Alex Azar to head the Department of Health and Human Services department was a major disappointment. As president of Eli Lilly USA, Azar oversaw major price hikes on lifeline medications, such as insulin.
Appealing to both his base and popular opinion, President Trump could use his executive authority immediately to more expressly permit Americans to buy medication from international pharmacies.
Tagged with: Alex Azar, Eli Lilly, executive authority, State of The Union, trump